There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...

CAMBRIDGE, MA, USA I March 11, 2025 I Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase ...

There are lots of interesting companies that make Bedford their home. Below is a quick recap of what’s happening around town ...

It was five years ago today that then-Gov. Charlie Baker declared a State of Emergency in Massachusetts due to the rapidly ...

Denali Therapeutics Inc.’s DNLI share price has dipped by 10.43%, which has investors questioning if this is right time to buy.

Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...

Japanese drugmaker Eisai Inc. will lay off 57 employees in Nutley between the end of March and May, public records show, as the pharmaceutical company shaves off 7% of its U.S. workforce. The New ...

and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and ...

Biogen Inc. discovers, develops ... The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. As of March 14, 2025, argenx SE had a $36.4 billion market capitalization, ...

European regulators “reaffirmed” a positive view of Eisai and Biogen’s Alzheimer’s drug after conducting a new safety review. Leqembi and Eli Lilly’s rival drug Kisunla modestly delay the progression ...